Ingevity Corporation (NYSE:NGVT) is a specialty chemicals and materials company that focuses on creating products that enhance the performance of a variety of industries, including automotive, construction, and agriculture. The company is known for its innovative solutions and sustainable practices. Ingevity competes with other chemical companies like Eastman Chemical Company and Cabot Corporation.
On August 7, 2025, John McNulty from BMO Capital set a price target of $62 for NGVT. At that time, the stock was trading at $49.69, suggesting a potential increase of approximately 24.77%. This optimistic outlook comes shortly after Ingevity's Q2 2025 earnings conference call, which took place on August 5, 2025. The call, led by President and CEO David H. Li, provided insights into the company's financial performance and strategic direction.
Currently, NGVT's stock is priced at $49.65, reflecting a slight increase of approximately 1.54% or $0.76. The stock has shown some volatility, with today's trading range between $49.33 and $50.19. Over the past year, NGVT has experienced a high of $51.67 and a low of $28.49, indicating significant fluctuations in its market performance.
Ingevity's market capitalization is approximately $1.81 billion, with a trading volume of 130,787 shares on the NYSE. This market cap reflects the company's overall value in the stock market, calculated by multiplying the current share price by the total number of outstanding shares. The trading volume indicates the number of shares being bought and sold, which can impact the stock's price movement.
